16/17- Antineoplastic agents Flashcards

1
Q

folate is required for the synthesis of ..,

A

purines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

primary target of methotrexate

A

dihydrofolate reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 actions of methotrexate

A
  • reduces synthesis of purines
  • reduces synthesis of dTMP by inhibiting the necessary cofactor for thymidylate synthetase

—> reduces cellular proliferation and induces cellular death by preventing synthesis of RNA and DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

used to reduce methotrexate toxicity

A

leucovorin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA 5-fluorouracil

A

metabolised to FdUMP which inhibits thymidylate synthase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

5-FU causes damage by..

A

decreasing levels of dTMP and by incorporating into DNA and RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

prodrug of 5-FU taken orally

A

capecitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse effects 5-FU

A

oral and GI ulcers

bone marrow suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

specific treatment uses for cytarabine

A

acute myelogenous leukemia

only used in treatment of hematologic malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

during what stage of the cell cycle is cytarabine active?

A

only active in s phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA cytarabine

A

incorporation into DNA inhibits DNA polymerase thus halting elongation of DNA molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

inactivates cytarabine

A

cytidine deaminase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

toxicity of cytarabine

A

cerebellar syndrome because CNS is exposed to higher levels than the rest of the body

-> dysarthria, nystagmus, ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does cytarabine need in order to become activated?

A

nucleoside transporter and deoxycytidine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cytotoxic effects of gemcitabine

A
  • incorporated into DNA -> inhibit synthesis and function

- ihibits ribonucleotide reductase (decrease dNTPS for DNA synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what enzyme is necessary for 6TG and 6MP to act?

A

hypoxanthine-guanine phosphoribosyl transferase HGPRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA 6-TG and 6-MP

A

incorporation into DNA

stop purine synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA fludarabine

A

incorporated into DNA and RNA

inhibits DNA pol and ribonucleotide reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what enzyme is necessary to activate fludarabine?

A

deoxycytidine kinase

also necessary to activate cladribine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

standard therapy for hairy cell leukemia

A

cladribine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA cladribine

A

incorporated into DNA

potent inhbitor of ribonucleotide reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

cytotoxic MOA methotrexate

A

inhbits dihydrofolate reductase –> reduces precursors for RNA and DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

cytotoxic MOA 5-FU

A

incorporated into DNA and RNA –> inhibts synthesis and function

inhbits thymidylate synthetase which reduces DNA precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

cytotoxic MOA cytarabine

A

incorporated into DNA and RNa, which inhbits synthesis and function

inhibits DNA synthesis by inhibiting DNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
cytotoxic MOA gemcitabine
incorporated into DNA, which inhibits synthesis and function inhibits ribonucleotide reductase which reduces precursors for DNA
26
cytotoxic MOA 6-MP and 6-TG
incorporated into DNA which inhibits synthesis and function reduce precursors for RNA and DNA by inhibiting purine synthesis
27
cytotoxic MOA fludarabine
incorporated into DNA and RNA which inhibits synthesis and function inhibits DNA polymerase and ribonucleotide reductase
28
cytotoxic MOA cladribine
incorporated into DNA causes strand breaks potent inhibitor of ribonucleotide reductase which reduces DNA precursors
29
most common binding site for alkylating agents
seven nitrogen group of guanine --> causes DNA crosslinking and strand breakage
30
are alkylating agents specific to a certain stage of the cell cycle?
nope - toxic in all stages
31
most common adverse affect of cyclophosphamide
hemorrhagic cystits
32
what drug is used to combat hemorrhagic cystitis of cyclophosphamide?
mesna
33
why is carmustine commonly used to treat brain tumors?
lipophilic and can cross BBB
34
3 common adverse effects of alkylating agents
can cause leukemia (4 yrs later peak incidence) blistering properties that damage veins bone marrow suppresion and damage to intestinal mucosa
35
increased expression of MGMT stops what drugs?
alkylating agents prevents permanent DNA damage by removing alkyl groups from guanin before cross-links form
36
what can inactivate alkylating agents
glutathione
37
what transports non-classical alkylating agents into cells?
Cu2+ transporter
38
would you rather use cisplatin or carboplatin with another drug that cause a lot of myelosuppresion?
cisplatin carboplatin causes more myelosuppression but less nausea, neurotoxicity, ototoxicity and nephrotoxicity than cisplatin
39
unique adverse effects of cisplatin
peripheral neuropathy tinnitus nephrotoxicity hypomagnesia
40
antimicrotubule agents
vinblastine and vincristine prevent formation of microtubules and kill in mitosis
41
which is more neurotoxic: vincristine or vinblastine?
vincristine has more neurological side effects but vinblastine has more significant myelosuppression
42
antimicrotubule agent
paclitaxel kills in mitosis by preventing the de-polymerization of microtubules
43
major adverse effect of paclitaxel
peripheral neuropathy and bone marrow toxiicity
44
what drug is used with paclitaxel to reduce myelosuppression
filgrastim
45
inhibitors of topoisomerase I
irinotecan | topotecan
46
class II topoisomerase inhibitor
Etoposide
47
fuction of topoisomerases
cut DNA, unwind it, and repair the cut during DNA replication
48
cytotoxic antibiotics
doxorubicin | bleomycin
49
cytotoxic MOA of doxorubicin
intercalates with DNA --> inhibition of DNA polymerase also inhibits topoisomerase II --> double strand breaks
50
unique adverse effect of doxorubicin and solution
irreversible cardiomyopathy due to free radical formation dexrazoxane an iron chelator can reduce cardiotoxicity
51
MOA bleomycin
small peptide that binds to DNA and causes single and double strand breaks
52
what stage of the cell cycle does bleomycin affect>
causes cells to arrest in G2 pahse
53
what is the unique side effect for bleomycin?
pulmonary toxicity that is cumulative and irreversible BUT good news it is minimally myelosuppressive
54
MOA of the glucocorticoids prednisone and dexamethasone
inhbit lymphocyte proliferation reduce intracranial pressure with brain tumors reduce adverse effects such as nausea and vomiting
55
partial estrogen receptor antagonist
tamoxifen
56
aromatase inhbitor
anatrozole
57
androgen receptor antagonist useful for treatment of prostate cancer
flutamide prevents dihydrotestosterone from binding to androgen receptors
58
GnRH receptor agonist
leuuprolide and goserelin cause desensitizationof GnRH receptor on pituitary used to treat prostate cancer
59
GnRh receptor antagonist
degarelix used to treat prostate cancer
60
risk of tamoxifen
increase risk for endometrial cancer
61
what does aromatase do?
converts testosterone into estrogen
62
used to treat estrogen-sensitive breast tumors in post-menopausal women
anastrozole
63
used to treat breast cancer with Her-2 amplified
trastuzumab blocks her-2 mediated signaling and can induce antibody dependent cytotoxicity
64
toxicity of trastuzumab
cardiotoxicity
65
used to treat EGFR expressing colorectal tumors in combination with other drugs
cetuximab
66
what causes tumors to be resistance to cetuximab
activating mutations in RAS routine tests of RAS mutational status need to be preformed
67
binds to VEGF which prevents VEGF binding to VEGFR to promote angiogenesis
bevacizumab used to treat colorectal and breast cancer
68
adverse effects bevacizumab
HTN increased thrombosis or bleeding increased risk GI perforation decreased wound healing
69
inhibits both EGFR and HER2 kinase activity
lapatinib
70
use of lapatinib
used in combination with capecitabine to treat Her2, trastuzumab refractory breast cancer
71
first line treatment for metastatic nonsmall cell lung carcinoma
erlotinib
72
MOA erlotinib
EGFR inhibitor and ATP competitive inhibitor
73
treatment for chronic myelogenous leukemia caused by philadelphia chromosome
imatinib inhibits the consitiutively active AL
74
used to treat acute lymphoblastic leukemia
asparaginase
75
MOA asparaginase
starve tumor cells of L-asparagine
76
proteasome inhibitor
bortezomib by inhibiting the proteasome, it elevates levels of p53
77
adverse effects of bortezomib
thrombocytopenia, peripheral neuropathy, anemia
78
used to treat renal cell carcinoma
temsirolimus
79
MOA temsirolimus
inhibition of mTOR complex 1 reduces prtn translation, promotes cell cycle inhibition, and promotes apoptosis NOT mTORC2 (resistant)